294 related articles for article (PubMed ID: 32965016)
1. Advances in SARS-CoV-2: a systematic review.
Bai YX; Xu YH; Wang X; Sun C; Guo Y; Qiu S; Ma KW
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9208-9215. PubMed ID: 32965016
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
3. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
4. Coronavirus disease 2019: a clinical review.
Yang CL; Qiu X; Zeng YK; Jiang M; Fan HR; Zhang ZM
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4585-4596. PubMed ID: 32373999
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
Khalaf K; Papp N; Chou JT; Hana D; Mackiewicz A; Kaczmarek M
Front Immunol; 2020; 11():570927. PubMed ID: 33123144
[TBL] [Abstract][Full Text] [Related]
6. An update on novel COVID-19 pandemic: a battle between humans and virus.
Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
[TBL] [Abstract][Full Text] [Related]
7. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
8. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Wang D; Li Z; Liu Y
J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
[TBL] [Abstract][Full Text] [Related]
9. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
10. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
Cao YC; Deng QX; Dai SX
Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
Zhou H; Fang Y; Xu T; Ni WJ; Shen AZ; Meng XM
Br J Pharmacol; 2020 Jul; 177(14):3147-3161. PubMed ID: 32368792
[TBL] [Abstract][Full Text] [Related]
13. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
15. COVID-2019: update on epidemiology, disease spread and management.
Sahu KK; Mishra AK; Lal A
Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
[TBL] [Abstract][Full Text] [Related]
16. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
17. An update on the status of COVID-19: a comprehensive review.
Zhao N; Zhou ZL; Wu L; Zhang XD; Han SB; Bao HJ; Shu Y; Shu XG
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4597-4606. PubMed ID: 32374000
[TBL] [Abstract][Full Text] [Related]
18. Understanding of COVID-19 based on current evidence.
Sun P; Lu X; Xu C; Sun W; Pan B
J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
20. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Carradori S
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
